IL1B and breast carcinoma: On the other hand, this secretome could be beneficial, as IL-1β was shown to inhibit melanoma growth in vivo [72,73], and IL-6, as well as IL-8, could not only induce but also reinforce senescence in the MCF-7 breast cancer cell line [40,74,75].